PROVIDER PROFILE · NPI 1700821329
Magdi Gindi
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
432
Beneficiaries
—
Total drug cost
$10K
Distinct drugs
25
Brand share
5.8%
Top prescribed drugs
Atorvastatin Calcium38 claims
Simvastatin36 claims
Metformin Hcl32 claims
Ketoconazole30 claims
Losartan Potassium23 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$566
Payment records
20
By payment type
Food and Beverage$566
Top paying entities
Food and Beverage$566
REFERRAL NETWORK
Where Magdi Gindi's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Biocorp Clinical Lab Inc Clinical Laboratory · Whittier, CA | 112 | 473 |
| Adelaida Bustos Diagnostic Radiology · Los Angeles, CA | 18 | 31 |
| ENVOY HEALTH CARE, INC. | 17 | 35 |
| Nabila Gindi General Practice · Los Angeles, CA | 16 | 49 |
| Unilab Corporation Clinical Laboratory · West Hills, CA | 16 | 25 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE